Suven Life Sciences reports Profit after tax of Rs -85.09 Mln, in the March 2021 quarter

04 May 2021 Evaluate
The Sales for the quarter ended March 2021 of Rs. 15.57 million declined by -82.02% from Rs. 86.60 millions.The Net Loss for the quarter ended March 2021 is Rs. -85.09 millions as compared to Net Loss of Rs. -25.64 millions of corresponding quarter ended March 2020Operating profit Margin for the quarter ended March 2021 slipped to -71.55% as compared to 9.19% of corresponding quarter ended March 2020


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202103 202003 % Var 202103 202003 % Var 202103 202003 % Var
Sales 15.57 86.60 -82.02 134.78 144.15 -6.50 134.78 144.15 -6.50
Other Income 13.23 29.97 -55.86 77.54 140.36 -44.76 77.54 140.36 -44.76
PBIDT -71.55 9.19 -878.56 -227.93 -212.80 7.11 -227.93 -212.80 7.11
Interest 2.42 2.32 4.31 8.15 4.87 67.35 8.15 4.87 67.35
PBDT -73.97 6.87 -1176.71 -236.08 -217.67 8.46 -236.08 -217.67 8.46
Depreciation 10.66 10.52 1.33 43.46 41.69 4.25 43.46 41.69 4.25
PBT -84.63 -3.65 2218.63 -279.54 -259.36 7.78 -279.54 -259.36 7.78
TAX 0.46 21.99 -97.91 -53.23 -121.83 -56.31 -53.23 -121.83 -56.31
Deferred Tax 0.46 2.27 -79.74 -53.23 -141.55 -62.39 -53.23 -141.55 -62.39
PAT -85.09 -25.64 231.86 -226.31 -137.53 64.55 -226.31 -137.53 64.55
Equity 127.28 127.28 0.00 127.28 127.28 0.00 127.28 127.28 0.00
PBIDTM(%) -459.54 10.61 -4430.36 -169.11 -147.62 14.56 -169.11 -147.62 14.56

Suven Life Sciences Share Price

169.35 0.45 (0.27%)
10-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.25
Dr. Reddys Lab 1251.10
Cipla 1489.15
Zydus Lifesciences 923.70
Lupin 2055.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×